Krista Davis - 11 Dec 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Signature
/s/ Krista Davis, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
11 Dec 2024
Net transactions value
-$60,000
Form type
4
Filing time
12 Dec 2024, 17:08:37 UTC
Previous filing
13 Sep 2024
Next filing
18 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale $60,000 -1,000 -2% $60.00 49,059 11 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024.